The mammalian anti-proliferative BTG/Tob protein family

Journal of Cellular Physiology

Volumn 222, Issue 1, 2010, Pages 66-72

  Winkler, G Sebastiaan ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CHEMOKINE RECEPTOR CCR4; DNA BINDING PROTEIN; MESSENGER RNA; PROTEIN BTG; PROTEIN BTG1; PROTEIN BTG2; PROTEIN BTG3; PROTEIN BTG4; PROTEIN TOB; PROTEIN TOB1; PROTEIN TOB2; RETINOIC ACID; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADENYLATION; AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER PATIENT; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; DNA BINDING; EFFECTOR CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; MAMMAL; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE PROTEINS; CELL PROLIFERATION; HUMANS; MAMMALS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA;

EID: 73949116438     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21919     Document Type: Review

References (76)

1. Albrecht M, Lengauer T. 2004. Survey on the PABC recognition motif PAM2. Biochem Biophys Res Commun 316:129-138.
2. Aslam A, Mittal S, Koch F, Andrau JC, Winkler GS. 2009. The Ccr4-Not deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation. Mol Biol Cell 20:3840-3850.
3. Bedford MT, Clarke SG. 2009. Protein arginine methylation in mammals: Who, what, and why. Mol Cell 33:1-13.
4. Berthet C, Guehenneux F, Revol V, Samarut C, Lukaszewicz A, Dehay C, Dumontet C, Magaud JP, Rouault JP. 2002. Interaction of PRMT1 with BTG/TOB proteins in cell signalling: Molecular analysis and functional aspects. Genes Cells 7:29-39.
5. Bianchin C, Mauxion F, Sentis S, Seraphin B, Corbo L. 2005. Conservation of the deadenylase activity of proteins of the Caf1 family in human. RNA 11:487-494.
6. Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV. 2006. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev 20:236-252.
7. Bradbury A, Possenti R, Shooter EM, Tirone F. 1991. Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci USA 88:3353-3357.
8. Buanne P, Corrente G, Micheli L, Palena A, Lavia P, Spadafora C, Lakshmana MK, Rinaldi A, Banfi S, Quarto M, Bulfone A, Tirone F. 2000. Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics 68:253-263.
9. Busson M, Carazo A, Seyer P, Grandemange S, Casas F, Pessemesse L, Rouault JP, Wrutniak-Cabello C, Cabello G. 2005. Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. Oncogene 24:1698-1710.
10. Chen J, Chiang YC, Denis CL. 2002. CCR4, a 3′-5′ poly(A) RNA and ssDNA exonuclease, is the catalytic component of the cytoplasmic deadenylase. EMBO J 21:1414-1426.
11. Cho JW, Kim JJ, Park SG, Lee DH, Lee SC, Kim HJ, Park BC, Cho S. 2004. Identification of B-cell translocation gene 1 as a biomarker for monitoring the remission of acute myeloid leukemia. Proteomics 4:3456-3463.
12. Collart MA, Timmers HT. 2004. The eukaryotic Ccr4-not complex: A regulatory platform integrating mRNA metabolism with cellular signaling pathways? Prog Nucleic Acid Res Mol Biol 77:289-322.
13. Cougot N, Babajko S, Seraphin B. 2004. Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 165:31-40.
14. Daugeron MC, Mauxion F, Seraphin B. 2001. The yeast POP2 gene encodes a nuclease involved in mRNA deadenylation. Nucleic Acids Res 29:2448-2455.
15. Donato LJ, Suh JH, Noy N. 2007. Suppression ofmammary carcinoma cell growth by retinoic acid: The cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer Res 67:609-615.
16. Dupressoir A, Morel AP, Barbot W, Loireau MP, Corbo L, Heidmann T. 2001. Identification of four families of yCCR4- and Mg2+-dependent endonuclease-related proteins in higher eukaryotes, and characterization of orthologs of yCCR4 with a conserved leucine-rich repeat essential for hCAF1/hPOP2 binding. BMC Genomics 2:9.
17. el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A. 2002. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene 21:6772-6778.
18. Ezzeddine N, Chang TC, Zhu W, Yamashita A, Chen CY, Zhong Z, Yamashita Y, Zheng D, Shyu AB. 2007. Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation. Mol Cell Biol 27:7791-7801.
19. Farioli-Vecchioli S, Tanori M, Micheli L, Mancuso M, Leonardi L, Saran A, Ciotti MT, Ferretti E, Gulino A, Pazzaglia S, Tirone F. 2007. Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3. FASEB J 21:2215-2225.
20. Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA, Walden PD. 2001. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 22:1271-1279.
21. Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR. 1991. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266:14511-14518.
22. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. 2003. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574.
23. Funakoshi Y, Doi Y, Hosoda N, Uchida N, Osawa M, Shimada I, Tsujimoto M, Suzuki T, Katada T, Hoshino S. 2007. Mechanism of mRNA deadenylation: Evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases. Genes Dev 21:3135-3148.
24. Goldstrohm AC, Wickens M. 2008. Multifunctional deadenylase complexes diversify mRNA control. Nat Rev Mol Cell Biol 9:337-344.
25. Guardavaccaro D, Corrente G, Covone F, Micheli L, D'Agnano I, Starace G, Caruso M, Tirone F. 2000. Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 20:1797-1815.
26. Guehenneux F, Duret L, Callanan MB, Bouhas R, Hayette S, Berthet C, Samarut C, Rimokh R, Birot AM, Wang Q, Magaud JP, Rouault JP. 1997. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11:370-375.
27. Hata K, Nishijima K, Mizuguchi J. 2007. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement. Exp Cell Res 313:2356-2366.
28. Hiramatsu Y, Kitagawa K, Suzuki T, Uchida C, Hattori T, Kikuchi H, Oda T, Hatakeyama S, Nakayama KI, Yamamoto T, Konno H, Kitagawa M. 2006. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res 66:8477-8483.
29. Hong JW, Ryu MS, Lim IK. 2005. Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death. J Biol Chem 280:21256-21263.
30. Horiuchi M, Takeuchi K, Noda N, Muroya N, Suzuki T, Nakamura T, Kawamura-Tsuzuku J, Takahasi K, Yamamoto T, Inagaki F. 2009. Structural basis for the antiproliferative activity of the Tob-hCaf1 complex. J Biol Chem 284:13244-13255.
31. Ikematsu N, Yoshida Y, Kawamura-Tsuzuku J, Ohsugi M, Onda M, Hirai M, Fujimoto J, Yamamoto T. 1999. Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene 18:7432-7441.
32. Ito Y, Suzuki T, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Yamamoto T, Miyauchi A. 2005. Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett 220:237-242.
33. Iwanaga K, Sueoka N, Sato A, Sakuragi T, Sakao Y, Tominaga M, Suzuki T, Yoshida Y, Tsuzuku JK, Yamamoto T, Hayashi S, Nagasawa K, Sueoka E. 2003. Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett 202:71-79.
34. Jia S, Meng A. 2007. Tob genes in development and homeostasis. Dev Dyn 236:913-921.
35. Karmakar S, Foster EA, Smith CL. 2009. Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor. Int J Cancer 124:1841-1851.
36. Kawakubo H, Brachtel E, Hayashida T, Yeo G, Kish J, Muzikansky A, Walden PD, Maheswaran S. 2006. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Cancer Res 66:7075-7082.
37. Kawamura-Tsuzuku J, Suzuki T, Yoshida Y, Yamamoto T. 2004. Nuclear localization of Tob is important for regulation of its antiproliferative activity. Oncogene 23:6630-6638.
38. Lin WJ, Gary JD, Yang MC, Clarke S, Herschman HR. 1996. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271:15034-15044.
39. Lin WJ, Chang YF, Wang WL, Huang CY. 2001. Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Calpha-binding protein rPICK1. Biochem J 354:635-643.
40. Maekawa M, Nishida E, Tanoue T. 2002. Identification of the anti-proliferative protein Tob as a MAPK substrate. J Biol Chem 277:37783-37787.
41. Maekawa M, Yamamoto T, Nishida E. 2004. Regulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequences. Exp Cell Res 295:59-65.
42. Majid S, Dar AA, Ahmad A, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R. 2009. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30:662-670.
43. Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Yoshida M, Emi M, Nakamura Y, Onda M, Yoshida Y, Nishiyama A, Yamamoto T. 1996. Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene 12:705-713.
44. Matsuda S, Rouault J, Magaud J, Berthet C. 2001. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497:67-72.
45. Mauxion F, Faux C, Seraphin B. 2008. The BTG2 protein is a general activator of mRNA deadenylation. EMBO J 27:1039-1048.
46. Miyai K, Yoneda M, Hasegawa U, Toita S, Izu Y, Hemmi H, Hayata T, Ezura Y, Mizutani S, Miyazono K, Akiyoshi K, Yamamoto T, Noda M. 2009. ANA deficiency enhances bone morphogenetic protein-induced ectopic bone formation via transcriptional events. J Biol Chem 284:10593-10600.
47. Montagnoli A, Guardavaccaro D, Starace G, Tirone F. 1996. Overexpression of the nerve growth factor-inducible PC3 immediate early gene is associated with growth inhibition. Cell Growth Differ 7:1327-1336.
48. Morita M, Suzuki T, Nakamura T, Yokoyama K, Miyasaka T, Yamamoto T. 2007. Depletion of mammalian CCR4b deadenylase triggers elevation of the p27Kip1 mRNA level and impairs cell growth. Mol Cell Biol 27:4980-4990.
49. Okochi K, Suzuki T, Inoue J, Matsuda S, Yamamoto T. 2005. Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: Implication of Tob in translational control. Genes Cells 10:151-163.
50. Ou YH, Chung PH, Hsu FF, Sun TP, Chang WY, Shieh SY. 2007. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J 26:3968-3980.
51. Park S, Lee YJ, Lee HJ, Seki T, Hong KH, Park J, Beppu H, Lim IK, Yoon JW, Li E, Kim SJ, Oh SP. 2004. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Mol Cell Biol 24:10256-10262.
52. Passeri D, Marcucci A, Rizzo G, Billi M, Panigada M, Leonardi L, Tirone F, Grignani F. 2006. Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation. Mol Cell Biol 26:5023-5032.
53. Prevot D, Voeltzel T, Birot AM, Morel AP, Rostan MC, Magaud JP, Corbo L. 2000. The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation. J Biol Chem 275:147-153.
54. Prevot D, Morel AP, Voeltzel T, Rostan MC, Rimokh R, Magaud JP, Corbo L. 2001. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: Involvement in estrogen receptor alpha signaling pathway. J Biol Chem 276:9640-9648.
55. Rodier A, Marchal-Victorion S, Rochard P, Casas F, Cassar-Malek I, Rouault JP, Magaud JP, Mason DY, Wrutniak C, Cabello G. 1999. BTG1: A triiodothyronine target involved in the myogenic influence of the hormone. Exp Cell Res 249:337-348.
56. Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J, Magaud JP. 1992. BTG1, a member of a new family of antiproliferative genes. EMBO J 11:1663-1670.
57. Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A. 1996. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14:482-486.
58. Rouault JP, Prevot D, Berthet C, Birot AM, Billaud M, Magaud JP, Corbo L. 1998. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem 273:22563-22569.
59. Sasajima H, Nakagawa K, Yokosawa H. 2002. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system. Eur J Biochem 269:3596-3604.
60. Struckmann K, Schraml P, Simon R, Elmenhorst K, Mirlacher M, Kononen J, Moch H. 2004. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res 64:1632-1638.
61. Suzuki T, Matsuda S, Tsuzuku JK, Yoshida Y, Yamamoto T. 2001. A serine/threonine kinase p90rsk1 phosphorylates the anti-proliferative protein Tob. Genes Cells 6:131-138.
62. Suzuki T, Tsuzuku JK, Ajima R, Nakamura T, Yoshida Y, Yamamoto T. 2002. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 16:1356-1370.
63. Tirone F. 2001. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: Regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 187:155-165.
64. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T. 2008. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123-4132.
65. Tucker M, Staples RR, Valencia-Sanchez MA, Muhlrad D, Parker R. 2002. Ccr4p is the catalytic subunit of a Ccr4p/Pop2p/Notp mRNA deadenylase complex in Saccharomyces cerevisiae. EMBO J 21:1427-1436.
66. Tzachanis D, Freeman GJ, Hirano N, van Puijenbroek AA, Delfs MW, Berezovskaya A, Nadler LM, Boussiotis VA. 2001. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2:1174-1182.
67. Viswanathan P, Ohn T, Chiang YC, Chen J, Denis CL. 2004. Mouse CAF1 can function as a processive deadenylase/3′-5′-exonuclease in vitro but in yeast the deadenylase function of CAF1 is not required for mRNA poly(A) removal. J Biol Chem 279:23988-23995.
68. Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, Strahl BD, Briggs SD, Allis CD, Wong J, Tempst P, Zhang Y. 2001. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293:853-857.
69. Yanagie H, Tanabe T, Sumimoto H, Sugiyama H, Matsuda S, Nonaka Y, Ogiwara N, Sasaki K, Tani K, Takamoto S, Takahashi H, Eriguchi M. 2009. Tumor growth suppression by adenovirus-mediated introduction of a cell growth suppressing gene tob in a pancreatic cancer model. Biomed Pharmacother 63:275-286.
70. Yang X, Morita M, Wang H, Suzuki T, Yang W, Luo Y, Zhao C, Yu Y, Bartlam M, Yamamoto T, Rao Z. 2008. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity. Nucleic Acids Res 36:6872-6881.
71. Yoneda M, Suzuki T, Nakamura T, Ajima R, Yoshida Y, Kakuta S, Sudo K, Iwakura Y, Shibutani M, Mitsumori K, Yokota J, Yamamoto T. 2009. Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma. Cancer Sci 100:225-232.
72. Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H, Yamamoto T. 1998. ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene 16:2687-2693.
73. Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, Noda T, Yamamoto T. 2000. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103:1085-1097.
74. Yoshida Y, Hosoda E, Nakamura T, Yamamoto T. 2001. Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex. Jpn J Cancer Res 92:592-596.
75. Yoshida Y, Nakamura T, Komoda M, Satoh H, Suzuki T, Tsuzuku JK, Miyasaka T, Yoshida EH, Umemori H, Kunisaki RK, Tani K, Ishii S, Mori S, Suganuma M, Noda T, Yamamoto T. 2003a. Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev 17:1201-1206.
76. Yoshida Y, von Bubnoff A, Ikematsu N, Blitz IL, Tsuzuku JK, Yoshida EH, Umemori H, Miyazono K, Yamamoto T, Cho KW. 2003b. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling. Mech Dev 120:629-637.